Osteoprotegerin is associated with cardiovascular risk in hypertension and/or diabetes
Ana M. Blázquez-Medela, Luis García-Ortiz, Manuel A. Gómez-Marcos, José I. Recio-Rodriguez, Angel Sánchez-Rodríguez, José M. López-Novoa, Carlos Martínez-SalgadoVolume:
42
Année:
2012
Langue:
english
Pages:
9
DOI:
10.1111/j.1365-2362.2011.02619.x
Fichier:
PDF, 256 KB
english, 2012